Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mismatch Repair Protein Loss as a Prognostic and Predictive Biomarker in Breast Cancers Regardless of Microsatellite Instability
Nicola Fusco, Gianluca Lopez, Chiara Corti, et al.
JNCI Cancer Spectrum (2018) Vol. 2, Iss. 4
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Progress and challenges of immunotherapy in triple-negative breast cancer
Yinxing Zhu, Xuedan Zhu, Cuiju Tang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188593-188593
Closed Access | Times Cited: 177
Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: Guideline From the College of American Pathologists in Collaboration With the Association for Molecular Pathology and Fight Colorectal Cancer
Angela N. Bartley, Anne M. Mills, Eric Q. Konnick, et al.
Archives of Pathology & Laboratory Medicine (2022) Vol. 146, Iss. 10, pp. 1194-1210
Open Access | Times Cited: 89
PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?
Nicola Fusco, Elham Sajjadi, Konstantinos Venetis, et al.
Genes (2020) Vol. 11, Iss. 7, pp. 719-719
Open Access | Times Cited: 114
Immunotherapy for early breast cancer: too soon, too superficial, or just right?
Maria Alice Franzoi, Emanuela Romano, Martine Piccart
Annals of Oncology (2020) Vol. 32, Iss. 3, pp. 323-336
Open Access | Times Cited: 103
Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact
Konstantinos Venetis, Chiara Frascarelli, Luca Boscolo Bielo, et al.
European Journal of Cancer (2025) Vol. 217, pp. 115233-115233
Closed Access | Times Cited: 1
Targeting Immune-Related Biological Processes in Solid Tumors: We do Need Biomarkers
Fabio Pagni, Elena Guerini‐Rocco, Anne M. Schultheis, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 21, pp. 5452-5452
Open Access | Times Cited: 57
Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers
Vito Amodio, Gianluca Mauri, Nicole M. Reilly, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2638-2638
Open Access | Times Cited: 49
Breast Cancer Heterogeneity
Caterina Fumagalli, Massimo Barberis
Diagnostics (2021) Vol. 11, Iss. 9, pp. 1555-1555
Open Access | Times Cited: 46
Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization
Elham Sajjadi, Konstantinos Venetis, Roberto Piciotti, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 42
Microsatellite Instability: From the Implementation of the Detection to a Prognostic and Predictive Role in Cancers
Martina Amato, Renato Franco, Gaetano Facchini, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8726-8726
Open Access | Times Cited: 35
Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing Methods
Francesca Porta, Elham Sajjadi, Konstantinos Venetis, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 7, pp. 1176-1176
Open Access | Times Cited: 18
DNA damage response in breast cancer and its significant role in guiding novel precise therapies
Jiayi Li, Ziqi Jia, Dong Lin, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort
Angela Cheng, Samuel Leung, Dongxia Gao, et al.
Breast Cancer Research and Treatment (2019) Vol. 179, Iss. 1, pp. 3-10
Open Access | Times Cited: 48
Microsatellite instability and mismatch repair protein expressions in lymphocyte‐predominant breast cancer
Yoshiya Horimoto, May Thinzar Hlaing, Harumi Saeki, et al.
Cancer Science (2020) Vol. 111, Iss. 7, pp. 2647-2654
Open Access | Times Cited: 47
Mismatch Repair Deficiency and Microsatellite Instability in Triple-Negative Breast Cancer: A Retrospective Study of 440 Patients
Xinyu Ren, Yu Song, Jing Wang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 38
Immune Checkpoint Inhibitors in Triple Negative Breast Cancer: The Search for the Optimal Biomarker
Sadaf Qureshi, Nancy Chan, Mridula George, et al.
Biomarker Insights (2022) Vol. 17
Open Access | Times Cited: 25
Advances in diagnostic and therapeutic applications of mismatch repair loss in cancer
J T DeWitt, D Jimenez-Tovar, Aloran Mazumder, et al.
DNA repair (2025) Vol. 147, pp. 103822-103822
Open Access
<p>Strategies for Increasing the Effectiveness of Aromatase Inhibitors in Locally Advanced Breast Cancer: An Evidence-Based Review on Current Options</p>
Giulia Grizzi, Michele Ghidini, Andrea Botticelli, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 675-686
Open Access | Times Cited: 34
PTEN Expression as a Complementary Biomarker for Mismatch Repair Testing in Breast Cancer
Gianluca Lopez, Marianna Noale, Chiara Corti, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1461-1461
Open Access | Times Cited: 34
Current and potential immunohistochemical biomarkers for prognosis and therapeutic stratification of breast carcinoma
Andrea Ronchi, Francesca Pagliuca, Federica Zito Marino, et al.
Seminars in Cancer Biology (2020) Vol. 72, pp. 114-122
Closed Access | Times Cited: 34
Mismatch repair testing in breast cancer: the path to tumor-specific immuno-oncology biomarkers
Konstantinos Venetis, Elham Sajjadi, Svasti Haricharan, et al.
Translational Cancer Research (2020) Vol. 9, Iss. 7, pp. 4060-4064
Open Access | Times Cited: 33
Biomarkers for precision immunotherapy in the metastatic setting: hope or reality?
Elham Sajjadi, Konstantinos Venetis, Cristian Scatena, et al.
ecancermedicalscience (2020) Vol. 14
Open Access | Times Cited: 33
Triple-Negative Breast Cancer: Intact Mismatch Repair and Partial Co-Expression of PD-L1 and LAG-3
Shafei Wu, Xiaohua Shi, Jing Wang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 28
Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance
Vito Amodio, Simona Lamba, Rosaria Chilà, et al.
Cancer Cell (2022) Vol. 41, Iss. 1, pp. 196-209.e5
Open Access | Times Cited: 22
The molecular landscape of breast mucoepidermoid carcinoma
Konstantinos Venetis, Elham Sajjadi, Mariia Ivanova, et al.
Cancer Medicine (2023) Vol. 12, Iss. 9, pp. 10725-10737
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top